DEF 14A: Cross Country Healthcare Seeks Stockholder Approval for 2024 Omnibus Incentive Plan Amid Strong 2023 Performance

Cross Country Healthcare's proxy statement highlights a successful 2023 and proposes a new omnibus incentive plan for continued growth and alignment with stockholder interests.

Summary

• Cross Country Healthcare is seeking stockholder approval for its 2024 Omnibus Incentive Plan.
• The company celebrates a resilient 2023, achieving significant financial milestones despite post-COVID-19 challenges.
• Revenue guidance was surpassed in several quarters, with Adjusted EBITDA and EPS within projected ranges.
• The company highlights advancements in technology, including the rollout of Intellify and the relaunch of the Xperience app.
• Impressive growth was experienced across Physician Staffing, Education, and Homecare segments.
• The company exited the year with new business in vendor-neutral and managed service programs.
• The primary focus for the new fiscal year is maximizing returns on investments, expanding the client roster, and enhancing operational efficiency.
• The company has a robust balance sheet with no debt, positioning it for strategic investments and acquisitions.
• Opportunities for additional share repurchases, technology investments, and potential mergers and acquisitions are being explored.
• The company requests stockholder support for Board members, the 2023 executive compensation program, and other items outlined in the proxy.
• The Annual Meeting of Stockholders will be held virtually on May 14, 2024.
• The board recommends voting for the election of directors, ratification of the appointment of Deloitte & Touche LLP, approval of executive compensation, and approval of the 2024 Omnibus Incentive Plan.
• Fiscal 2023 revenue exceeded $2.0 billion, with Adjusted EBITDA of $144.4 million and an Adjusted EBITDA margin of 7.2%.
• The company repurchased 2.34 million shares of Common Stock for $57.6 million in Fiscal 2023.
• The 2024 Omnibus Incentive Plan authorizes the issuance of 2,400,000 shares, plus shares available from the prior plan.
• The company's three-year average burn rate is 1.38%.

Sentiment

Score: 7

Explanation: The document presents a generally positive outlook, highlighting strong financial performance and strategic initiatives. However, it also acknowledges challenges and areas for improvement, resulting in a moderately positive sentiment score.

Positives

• The company achieved significant financial milestones in 2023, surpassing revenue guidance and maintaining Adjusted EBITDA and EPS within projected ranges.
• The company has a robust balance sheet with no debt, positioning it for strategic investments and acquisitions.
• The company is exploring opportunities for additional share repurchases, technology investments, and potential mergers and acquisitions.
• The company's commitment to increasing stockholder value remains unwavering.
• The company has a strong cash flow of $248.5 million in Fiscal 2023.
• The company paid off its term loan and has no outstanding long-term debt.

Negatives

• The company did not achieve its threshold performance hurdles for Company Annual Adjusted EBITDA or Company Annual Revenue in Fiscal 2023, resulting in no awards for the Objective Bonus component for NEOs.
• The company's Fiscal 2023 Adjusted EBITDA margin of 7.2% was below the performance hurdle of 7.5%.

Risks

• The company acknowledges the challenges posed following the COVID-19 pandemic.
• The company faces risks related to cybersecurity, liquidity, operations, credit, regulatory compliance, and fiduciary responsibilities.
• The company is exposed to the risk of health-care professional burnout.

Future Outlook

The company's primary focus remains on maximizing returns on investments, expanding the client roster, and enhancing operational efficiency to bolster margins. The company believes it is well-positioned to pursue strategic investments and acquisitions that align with the evolving needs of its clients, candidates, and employees.

Management Comments

• Reflecting on 2023, Cross Country celebrates a year marked by resilience, innovation, and unwavering commitment to excellence.
• We are dedicated to maintaining profitability through the balancing of investments and cost-saving measures, including the utilization of our India operations.
• Our commitment to increasing stockholder value remains unwavering.

Industry Context

The company operates in the healthcare staffing industry, which is experiencing evolving models reshaping the nature of work globally. The company is focused on diversifying its offerings, embracing technology, and expanding its partnerships with clients and candidates.

Comparison to Industry Standards

• The Compensation Committee benchmarks NEO compensation against a peer group of 12 companies from both the healthcare services and staffing industries, including Addus HomeCare Corporation, Kelly Services, Inc., and AMN Healthcare Services, Inc.
• The company aims to position NEO base salaries and target total direct compensation opportunities at or near the 50th percentile of market values for comparable positions at industry peers.
• The company's three-year average burn rate of 1.38% is a metric used to assess equity usage relative to outstanding shares, which is a common practice in the industry.

Related Party Transactions

• Mark Fortunato, son-in-law of Kevin C. Clark, is employed by Cross Country Healthcare, Inc.
• The Company transacts business with Recruitics, a company related to Mr. Clark.
• The Company provided services to ChristianaCare, where Dr. Janice E. Nevin is President and CEO.

Stakeholder Impact

• The company's performance and strategic initiatives impact shareholders, employees, customers, and other stakeholders.
• The company is committed to increasing stockholder value.
• The company aims to provide optimal flexibility, compensation, and support to healthcare and educational talent.
• The company supports its communities through numerous volunteer programs, charitable giving, and other programs.

Next Steps

• Stockholders are requested to vote on the proposals outlined in the proxy statement.
• The company will hold its Annual Meeting of Stockholders on May 14, 2024.
• The company will continue to execute its strategy, focusing on maximizing returns on investments, expanding its client roster, and enhancing operational efficiency.

Key Dates

Keywords

Cross Country Healthcare, Omnibus Incentive Plan, Proxy Statement, Executive Compensation, Stockholders, Financial Performance, Board of Directors, Governance, Healthcare Staffing, Adjusted EBITDA, Revenue, Share Repurchase